Polyarthritis has been induced in rats by injection in oil of several immunogenic preparations such as mycobacteria, streptococcal cell walls and collagen Type II.l The non-immunogenic synthetic adjuvant, CP20961, has also been used to induce arthritis with a very similar clinical appearance and time course of developing disease.2 As with mycobacterial adjuvant disease, arthritis could be transferred to inbred rats of the same strain with lymphocytes from diseased animals3 indicating that, regardless of the immunogenic status of the arthritogen, lymphocytes were important in the initiation of arthritic disease.
In the case of CP20961, this has led to the proposal that it causes non-specific activation of immunity to an autoantigen, latent virus or viral protein, perhaps by activation of antigenprocessing cells or by intensifying the traffic in local lymph nodes draining the site of initiating injectant.'
The histopathology of CP2096 1 arthritis has been studied previously and found to resemble very closely that of other rat models of arthritis such as collagen Type II and mycobacterial adjuvant disease,' 2 4 though this does not infer a similar induction mechanism and pathogenesis for these differing arthritogens. With the advent of a range of monoclonal antibodies (MAbs) to various rat leucocyte markers the opportunity arose to examine more specifically the kinetics of the arrival of different cells in the lesions of paws from diseased animals and to monitor changes which occur in their lymphoid tissue. With this study in view a biotin-avidin immunohistoperoxidase technique to stain sections of unfixed whole joints was developed,5 which could withstand the application of successive multiple reagents and retain good morphology. With Disease progression caused lymphoid hypertrophy earlier than the appearance of inflammation in the joints. An increase in cell numbers in the paracortical areas of the draining lymph nodes was seen as early as day 4 , as well as the appearance of neutrophils and eosinophils in the red pulp of the spleen by day 11 . Eventually the ratio of the sizes of the red pulp to the white pulp in the spleen became obviously greater. (fig 1E) , bone marrow cells and infiltrating macrophages in soft tissue was evident. From day 18 onwards infiltrating cells at ligament and tendon attachment points were heavily stained as well as cells at invagination areas into eroding bone or streaming into bone marrow through the periosteum adjacent to cartilage. Staining with ED3 was always less intense than with ED 1 and ED2 and appeared to be specific for macrophages or their bone marrow precursor cells. Numbers of stained cells were not significantly increased above normal until day 18 onwards when they were principally found in synovial lining, in swirls of cells in soft tissue, and in bone marrow at the interface with cancellous bone in areas which had been invaded by inflammatory cells. Examination of adjacent sections suggested that not all macrophages in soft tissue which stained with EDI stained with ED3 (fig 2A and B) With the development of disease there was no significant change in pattern of staining with the macrophage markers, most of the lymphocyte markers or OX-6. ED2, since it stains macrophages mainly in the red pulp of spleen, served to confirm the relative increase in size of this area. The most significant change with developing disease, however, was seen with NDS64 and OX-39. By day 4 ( fig 3A) the numbers of lymphocytes staining in the paracortex of the draining lymph nodes had started to increase and were maintained until day 14 after which they declined. In the spleen numbers of stained lymphocytes in the PALS did not start to increase until day 1 (fig 3B) , particularly at the interface with the marginal zone and started to decline on day 21. Eosinophils seen in the red pulp stained strongly with these anti-IL-2R reagents, as previously reported. ., The first signs of swollen paws was on day 11. The immunohistopathology was very consistent from animal to animal, as has been shown with this model previously in terms of arthritic score."' Macrophages, stained by ED1 or OX-35, and polymorphonuclear cells were found on days 1 1 and 14 in growing pockets of oedema fluid adjacent to the ankle joint and in the surrounding soft tissue. Only the occasional cell in soft tissue or synovium was stained with the lymphocyte markers OX-19, OX-8 and R73 and it is unlikely therefore that T-lymphocytes had the opportunity to contribute directly to the initiation of joint inflammation occurring at that time. From day 18 onwards the predominant invading cells were mononuclear, staining with either macrophage or T-lymphocyte markers, and were found often in the same locality in joint synovium, at the interface with eroding bone and at tendon and ligament attachment points. Since staining with the MHC Class II antigen marker OX-6 was also enhanced in these areas the opportunity to process and present putative autoantigen to stimulate the local release of destructive enzymes was evident. Recent results by Meijers et all9 lend support to this view. They have shown in the same disease model that the local production of the cysteine proteinases Cathepsins B and L occurred in areas of eroding bone and cartilage invaded by macrophages which had been stained by ED1 or ED2. Enzyme levels reached a maximum 20 days after induction of arthritis and decreased as the disease entered natural remission.
IMMUNOHISTOLOGY OF NORMAL CONTROL PAWS
Examination of lymphoid tissue from diseased animals revealed the early production in lymph nodes draining the site of injection of CP2096 1 of T-lymphocytes bearing IL-2 receptors. Increased numbers of cells were seen as early as day 4 and were maintained until day 14 after which cell numbers decreased. A similar wave occurred later in the spleen on day 11 and was followed by an apparent decline on day 21 In conclusion, using a panel of MAbs specific for various subsets of lymphocytes and macrophages it has been possible to identify different stages of disease development and to comment on the possible role of these cells. Macrophages bearing the ED1 marker were among the first cells to arrive in the swollen paws and were the principal invading cells. These were followed by more mature macrophages bearing the ED2 and ED3 markers. Opportunity for them to interact with T-lymphocytes and MHC Class II antigenbearing cells in synovium, at ligament attachment points or at the face of eroding bone was evident.
The activity of T-lymphocytes in initiating CP20961 arthritis appeared to occur early in
